Skip to Content
Merck
CN
  • A novel FTL mutation responsible for neuroferritinopathy with asymmetric clinical features and brain anomalies.

A novel FTL mutation responsible for neuroferritinopathy with asymmetric clinical features and brain anomalies.

Parkinsonism & related disorders (2014-06-08)
Sébastien Moutton, Patricia Fergelot, Jean-Marc Trocello, Violaine Plante-Bordeneuve, Nada Houcinat, Emilie Wenisch, Vincent Larue, Pierre Brugières, Fabienne Clot, Didier Lacombe, Benoit Arveiler, Cyril Goizet
MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Ferritin from human liver, Type IV, 10 μg/mL